CardioGen Sciences
About:
Developing gene therapy solutions for orphan inherited arrhythmogenic diseases
Top Investors: Asset Management Ventures (AMV)
Description:
CardioGen Sciences is a biotechnology company that develops and offers gene therapy solutions for orphan-inherited arrhythmogenic diseases. It was founded in 2014 and is based in Palo Alto, California.
Total Funding Amount:
$526000
Headquarters Location:
Palo Alto, California, United States
Founded Date:
2014-01-01
Founders:
Louis Lange
Number of Employees:
11-50
Last Funding Date:
2014-11-06
IPO Status:
Private
Industries:
© 2025 bioDAO.ai